MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹19 Cr | ₹155 Cr | ₹-93 Cr | ₹106 Cr | ₹-19 Cr |
What is the latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2023 | ₹19 Cr |
Mar2022 | ₹155 Cr |
Mar2021 | ₹-93 Cr |
Mar2020 | ₹106 Cr |
Mar2019 | ₹-19 Cr |
How is Net Cash Inflow / Outflow of MANKIND PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2023 | ₹19 Cr | -87.48 | |
Mar2022 | ₹155 Cr | Positive | |
Mar2021 | ₹-93 Cr | Negative | |
Mar2020 | ₹106 Cr | Positive | |
Mar2019 | ₹-19 Cr | - |
Compare Net Cash Inflow / Outflow of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹83,809.5 Cr | -6.5% | -7.6% | 57% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹368,598.0 Cr | 2% | -0.3% | 59.8% | Stock Analytics | |
CIPLA | ₹114,654.0 Cr | 6% | 2.8% | 50.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,348.0 Cr | 3.7% | 5.8% | 17.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,499.0 Cr | 2.6% | 7.9% | 94.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,429.4 Cr | -1.3% | -2.8% | 31.5% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -6.5% |
-7.6% |
57% |
SENSEX | 1.7% |
-0.8% |
19% |
You may also like the below Video Courses